Diadema Partners LP Pure Tech Health PLC Transaction History
Diadema Partners LP
- $391 Billion
- Q3 2025
A detailed history of Diadema Partners LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Diadema Partners LP holds 7,324 shares of PRTC stock, worth $118,355. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,324
Previous 7,324
-0.0%
Holding current value
$118,355
Previous $126 Million
7.25%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
102KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL75KShares$1.21 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny17.8KShares$288,3100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$27,2290.02% of portfolio
-
Ubs Group Ag20Shares$3230.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M02Shares$320.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $451M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...